Protalix BioTherapeutics (PLX) Q2 2025 Earnings

9MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.05
0
0.05
0.1

Details

Expected EPS
0.08
Actual EPS
-0.05
Surprise EPS
-0.13
Surprise Percent
+162.5%

Description

Protalix BioTherapeutics (PLX) has reported earnings of -0.05 per share for Q2 2025.

0 Comments

Share your thoughts